Had another look at the comparison chart, PTX has had / is trials running for their PTX 100 / 200 but if only cell therapy is considerd then the "NO Patients treated" is correct.
In fact, as CARINA isn't listed, CHM and IMU are still the only ASX listed companies having cell therapy trials running. In a time when CAR-T is so hot in the US M&A market why isn't it hot here. Must be the Southern Hemisphere, almost everything is upside down, LOL.
GLTA
Chimeric: Media Thread, page-565
-
- There are more pages in this discussion • 143 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CHM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.0¢ |
Change
0.002(11.1%) |
Mkt cap ! $17.25M | |||
| Open | High | Low | Value | Volume |
| 1.9¢ | 2.0¢ | 1.9¢ | $26.18K | 1.372M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 736556 | 1.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.0¢ | 1462067 | 5 |
View Market Depth
| Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
| CHM (ASX) Chart |